Retinochoroidopathy after intravitreal anti-VEGF treatment

被引：0
|
作者：
Maier, M. [1 ]
Feucht, N. [1 ]
Lanzl, I. [1 ]
Kook, P. [1 ]
Lohmann, C. P. [1 ]
机构：
[1] Tech Univ Munich, Augenklin, D-81675 Munich, Germany
来源：
OPHTHALMOLOGE | 2009年 / 106卷 / 08期
关键词：
Injection of bevacizumab; Choroidal neovascularization; Age-related macular degeneration; BEVACIZUMAB AVASTIN TREATMENT; MACULAR DEGENERATION; INJECTION; PENETRATION; TEARS;
D O I：
10.1007/s00347-008-1839-3
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
A 74-year-old man presented with persistent metamorphopsias of the right eye 2 weeks after intravitreal injection of bevacizumab to treat choroidal neovascularization due to exudative age-related macular degeneration. The diagnosis reached was retinochoroiditis as an occult manifestation of sarcoidosis, possibly resulting from an intravitreal injection of bevacizumab. The patient received a prescription for 100 mg Ultralan to be taken daily for 3 days and then tapered in 3 day steps. During the further course no deterioration of the condition was observed.
引用
收藏
页码：729 / 734
页数：6
相关论文
共 50 条
  • [41] Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
    Good, Travis J.
    Kimura, Alan E.
    Mandava, Naresh
    Kahook, Malik Y.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (08) : 1111 - 1114
  • [42] Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
    Wahab, Charbel
    Ayash, Jad
    Sayegh, Kevin
    Sammouh, Fady
    Warrak, Elias L.
    [J]. CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (01): : 134 - 140
  • [43] Endophthalmitis Rates after Bilateral Same Day Intravitreal Anti-VEGF Injections
    Borkar, Durga S.
    Obeid, Anthony
    Su, Daniel
    Storey, Philip
    Gao, Xinxiao
    Kaiser, Richard
    Garg, Sunir
    Hsu, Jason
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [44] Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
    T. Barth
    F. Zeman
    H. Helbig
    M.-A. Gamulescu
    [J]. BMC Ophthalmology, 19
  • [45] Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy
    T. Barth
    F. Zeman
    H. Helbig
    M.-A. Gamulescu
    [J]. International Ophthalmology, 2018, 38 : 923 - 931
  • [46] Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
    Barth, T.
    Zeman, F.
    Helbig, H.
    Gamulescu, M. -A.
    [J]. BMC OPHTHALMOLOGY, 2019, 19 (01)
  • [47] Intravitreal anti-VEGF treatment for retinopathy of prematurity in infants with active adenoviral keratoconjunctivitis
    Kocluk, Yusuf
    Sukgen, Emine Alyamac
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2018, 37 (01) : 15 - 18
  • [48] RECURRENT INTRAVITREAL ANTI-VEGF TREATMENT IN HEMOPHILIA B PATIENT WITH OCULAR DEGENERATION
    Karadag, Keklik
    [J]. HAEMATOLOGICA, 2021, 106 (09) : 29 - 30
  • [49] Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
    Pastor-Pascual, Francisco
    Pastor-Pascual, Rafael
    Galvez-Perez, Patricia
    Dolz-Marco, Rosa
    Gallego-Pinazo, Roberto
    [J]. CLINICAL OPHTHALMOLOGY, 2022, 16 : 3959 - 3972
  • [50] Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy
    Barth, T.
    Zeman, F.
    Helbig, H.
    Gamulescu, M. -A.
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (03) : 923 - 931
12345